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Temporo-mandibular  joint  (TMJ)  metastases  are  a very  rare  event  and  only  73  cases  are  reported  in
literature.  In  about  40%  of cases  condylar  metastases  represent  the ﬁrst  clinical  manifestation  of  a tumor
of  elsewhere  and  may  then  allow  an  early  diagnosis.  However,  the  identiﬁcation  of this  tumoral  process
can  be difﬁcult  as in  over  50%  of  the  cases  it has  a nuanced  clinical  presentation  that is very similar  to
temporo-mandibular  disorders.eywords:
emporo-mandibular joint
emporo-mandibular metastasis
ondylar metastasis
emporo-mandibular joint disorders
The ﬁrst  case  of  metastatic  neuroendocrine  carcinoma  (NEC)  of the  temporo-mandibular  joint  (TMJ)
mimicking  a  temporo-mandibular  joint  disorder  is  presented  in this  report.  Furthermore,  an  extensive
review  of  the literature  has  been  performed  in  order  to  establish  a correct  diagnostic–therapeutic  protocol
for these  oncologic  patients.
©  2017  Asian  AOMS,  ASOMP,  JSOP,  JSOMS,  JSOM,  and  JAMI.  Published  by Elsevier  Ltd.  All  rights  reserved.euroendocrine carcinoma
. Introduction
Primary neoplasm of the mandible are more common than
etastatic disease, which represents only 1% of such tumors [1].
etastases are more commonly seen in the hematopoietically
ctive marrow of the skeletal bones. The cancellous bone at these
evels is indeed rich with sinusoidal vascular spaces that permit
umor cells penetration. The mandible is not a site of active marrow
n humans, particularly in older individuals. When cancellous mar-
ow is present, it is usually in the posterior aspect of the mandible
2].
If metastatic tumors of the mandible are rare, involvement of
he mandibular condyles by such growths is even rarer and, since
he ﬁrst description by De Cholnoky in 1941 [3], only 73 cases arePlease cite this article in press as: Vaira LA, et al. The mandibular cond
Case report and review of literature. J Oral Maxillofac Surg Med  Patho
eported in international literature.
An unusual case of metastatic neuroendocrine carcinoma (NEC)
f the temporo-mandibular joint (TMJ) is described in this report.
 AsianAOMS: Asian Association of Oral and Maxillofacial Surgeons; ASOMP: Asian
ociety of Oral and Maxillofacial Pathology; JSOP: Japanese Society of Oral Pathol-
gy; JSOMS: Japanese Society of Oral and Maxillofacial Surgeons; JSOM: Japanese
ociety of Oral Medicine; JAMI: Japanese Academy of Maxillofacial Implants.
∗ Corresponding author at: Via Pietro Canalis 12, 07100 Sassari, Italy.
E-mail address: luigi.vaira@gmail.com (L.A. Vaira).
ttp://dx.doi.org/10.1016/j.ajoms.2017.01.006
212-5558/© 2017 Asian AOMS, ASOMP, JSOP, JSOMS, JSOM, and JAMI. Published by ElseThe caecum was the site of arising of the primary tumor. This is the
ﬁrst report of metastatic TMJ  involvement of a NEC.
2. Case report
A 66-year-old Caucasian man  presented with an episode of
acute intestinal obstruction. His medical history included chronic
ischemic heart disease, hypercholesterolemia and hypertension. He
was therefore hospitalized at the Department of Surgery.
A total body CT scan was then executed showing a 9 cm cae-
cal mass with inﬁltration of the last ileal loop and the appendix.
A regional lymphonodal involvement and the presence of a single
liver metastasis were revealed. The patient underwent immediate
right colectomy with contemporary resection of the hepatic metas-
tasis. Histological examination revealed a Large Cell NEC of the
large bowel. The intestinal mucosa was inﬁltrated by a prolifer-
ation of tumor cell faintly arranged in a organoid growth pattern.
The tumor was  composed of large cells layers with scant cytoplasm
and enlarged, pleomorphic nuclei. Numerous apoptotic bodies and
mitotic ﬁgures were observed. High power magniﬁcation of theyle as uncommon metastatic site of neuroendocrine carcinoma:
l (2017), http://dx.doi.org/10.1016/j.ajoms.2017.01.006
tumor showed glandular differentiation and prominent intracyto-
plasmic mucin vacuoles, yielding a “signet ring cell” appearance.
Tumor cells showed immunoreactivity for chromogranin and Ki-
67; labeling index was  95% (Fig. 1).
vier Ltd. All rights reserved.
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Fig. 1. Histologic features of caecum NEC. A (H&E, 20×): The intestinal mucosa is inﬁltrated by a proliferation of tumor cell faintly arranged in a organoid pattern. B (H&E,
4 rged, pleomorphic nuclei. Numerous apoptotic bodies and mitotic ﬁgures are observed. C
( ation and prominent intracytoplasmic mucin vacuoles of tumors cells, yielding a “signet
r tivity for chromogranin. Ki-67 labeling index was  95%.
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n0×):  The tumor is composed of sheets of large cells with scant cytoplasm and enla
H&E,  100×): High-power magniﬁcation of the tumor showing glandular differenti
ing  cell” appearance. D (Peroxidase stain, 40×): The tumor cells show immunoreac
During the post-operative period the patient complained
ngravescent right TMJ  pain and was referred to Maxillo-Facial
urgery Department for evaluation.
He reported that, actually, right TMJ  pain and limitation of jaw
ovements started about 8 months before. For that problem he
lready turned to his dentist that, in the suspicion of a TMJ  disor-
er, prescribed NSAIDs and myorelaxant therapy. Two weeks after,
ue to the symptoms persistence, the patient performed radiologi-
al exams. Orthopantomograph and dynamic TMJ  radiographs were
otally negative. TMJ  magnetic resonance, of which the patient had
o images, referred anterior displacement of the right disk, without
eduction, intra-articular effusion and morphological alterations of
he condyle compatible with arthritic degeneration. Clinical and
adiological diagnosis of not reducible TMJ  disk anterior displace-
ent was then made and the patient begins a conservative therapy
ith occlusal bite that was continued, without any beneﬁt, for 5
onths until the admission at the Department of Surgery.
Clinical examination of the patient did not show masses or
welling of the right TMJ, masticatory muscles appeared contracted
nd painful. The patient complained pain both at rest (VAS 5) and
uring mandibular movement (VAS 9). Maximum mouth opening
as 15 mm with right deviation; left lateral excursion was 2 mm
hereas there was no restriction of the right lateral excursion.
arotid glands secretion was clear and the patient did not show
ervical lymphadenopathy. The oral cavity inspection was  normal.
here was deep bite, Class II occlusion with complete molar eden-
ulism.
To investigate the presence of a TMJ  metastatic lesion, maxillo-
acial contrasted CT scan was then performed showing structuralPlease cite this article in press as: Vaira LA, et al. The mandibular cond
Case report and review of literature. J Oral Maxillofac Surg Med  Patho
ubversion of the right condyle with osteosclerotic areas alter-
ate to 3–5 mm in diameter osteolytic lesions. The periosteum andFig. 2. Right TMJ  CT-scan showing osteosclerotic areas alternate to 3–5 mm in diam-
eter osteolytic lesions.
the lateral pterygoid muscle presented increased thickness and
oedema without others signiﬁcant alterations (Fig. 2).
The patient was submitted to open biopsy, frozen sections
conﬁrmed the malignancy suspicion. Condylectomy with healthyyle as uncommon metastatic site of neuroendocrine carcinoma:
l (2017), http://dx.doi.org/10.1016/j.ajoms.2017.01.006
margins was then performed in the same surgery (Fig. 3). Deﬁnitive
histologic examination conﬁrmed the diagnosis of metastatic lesion
showing epithelial scattered signet-ring cells containing intracyto-
plasmic mucina and poorly formed glandular lumen arranged in
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lusters and island growing within the bone. Tumoral cells were
mmunoreactive for chromogranin A and Ki-67, labeling index was
0% (Fig. 4).
ig. 4. Histologic features of condylar NEC metastasis. A (H&E, 4×): Epithelial tumor cells ar
arcinoma cells show scattered signet-ring cells containing intracytoplasmic mucina and p
ells  show a signet-ring appearance with cell containing intracytoplasmic mucina. D (Pe
i-67.  The labeling index is 80%. PRESS
ry, Medicine, and Pathology xxx (2017) xxx–xxx 3
After surgery, the patient was subjected to regional radiother-
apy associated with chemotherapy (streptozotocin in combination
with 5-ﬂuorouracil). Three months after surgery a new total body
CT scan has been executed showing the appearance of pulmonary
and hepatic metastases. The rapid deterioration in the patient’s
condition led to his death six months after diagnosis.
3. Discussion
NEC of the colon and rectum are quite rare, representing approx-
imately 0.3–0.1% of all colorectal carcinomas [4,5]. The growth
patterns and cytological features are typical of neuroendocrine
tumors. The presence of neurosecretory granules in the cytoplasm
of tumor cells detected by electron microscopy is characteristic.
Furthermore, neuroendocrine carcinomas typically stain for the
immunohistochemical markers synaptophysin, chromogranin, or
neuron-speciﬁc enolase. Compared with colo-rectal adenocarcino-
mas, NEC have a signiﬁcantly poorer prognosis and most patients
(around 70%) had metastatic disease at the time of diagnosis. The
metastatic pattern is relatively consistent and includes regional
lymphatics and lymphnodes, other than the liver and the lungs
[6]. Bone metastases are less common, although their frequency
is increasing due to improvements in surgical and medical man-
agement of these patients.
Bone metastases mechanism of NEC showed the spread of neo-
plastic cells from the primary tumor invading blood vessels and
spreading as emboli to distant regions, such as the bone. Malig-yle as uncommon metastatic site of neuroendocrine carcinoma:
l (2017), http://dx.doi.org/10.1016/j.ajoms.2017.01.006
through extravasations, were they then proliferate. NEC’s cells pro-
duce different chemokines, thus both osteoblastic and osteolytic
metastases can be observed [7].
ranged in clusters and islands are growing within the bone. B (H&E, 40×): Clusters of
oorly formed glandular lumen. C (H&E, 100×): Small cluster of epithelial carcinoma
roxidase stain, 40×): The tumor cells are immunoreactive for chromogranin A and
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Table 1
Report of condylar metastasis in international literature (1941–2016) [Abbreviations: NR: not reported; w: week; m:  month; y: year].
Authors Previous malignancy Presenting symptoms Primary site Tumor type Treatment Prognosis
De Cholnoky, 1941 [3] Yes Not reported Toe Melanoma NR NR
Thoma,  1947 [11] No TMJ  dysfunction Unknown Adenocarcinoma NR NR
Thoma,  1947 [11] No TMJ  dysfunction Unknown Transitional cell carcinoma NR NR
Salman,  1954 [12] 1 m before Hard mass Uterus Squamous cell carcinoma None Died 3 m later
Blackwood, 1956 [13] 3 m before Swelling and trismus Breast Adenocarcinoma None Died 4 m later
Ameli,  1965 [14] No Not reported Lung Bronchogenic carcinoma NR NR
Worth,  1966 [15] No TMJ  dysfunction Rectum Adenocarcinoma NR NR
Epker,  1969 [16] 5 y before Pathologic fracture Breast Adenocarcinoma RT Died 1 m later
Hartman,  1973 [17] 5 m before TMJ  dysfunction Breast Adenocarcinoma NR NR
Agerberg,  1974 [18] 2 y before TMJ  dysfunction Breast Adenocarcinoma RT/CT Died 5 m later
Butler,  1975 [19] 2 y before TMJ  dysfunction Breast Melanoma NR NR
Mace,  1978 [20] 3 y before Swelling, trismus and mental paresthesia Breast Adenocarcinoma Tumor resection Died 6 m later
Wolujewicz, 1980 [21] No Swelling Prostate Adenocarcinoma RT Died shortly after
Mizukawa,  1980 [22] 3 y before TMJ  dysfunction Breast Adenocarcinoma NR NR
Compère,  1981 [23] No Swelling and trismus Lung Bronchogenic carcinoma NR NR
Compère,  1981 [23] No Swelling and trismus Pancreas NR NR NR
Compère,  1981 [23] 6 m before TMJ dysfunction Breast Adenocarcinoma NR NR
Donazzan, 1981 [24] 21 y before TMJ  dysfunction Lung Bronchogenic carcinoma NR NR
Gerlach,  1982 [25] NR Swelling and pain Lung Bronchogenic carcinoma RT Died 8 m later
Giles,  1982 [26] 6 y before TMJ  dysfunction Rectum Adenocarcinoma NR NR
Peacock,  1982 [27] No TMJ  dysfunction Lung Bronchogenic carcinoma RT Died 3 m later
DeBoom,  1985 [28] No Pathologic fracture Prostate Adenocarcinoma NR NR
Owen,  1985 [29] No TMJ  dysfunction Lung Adenocarcinoma NR NR
Hecker,  1985 [30] No TMJ  dysfunction Unknown Adenocarcinoma NR NR
Tatcher,  1986 [31] NR Swelling Prostate Adenocarcinoma NR NR
Sokolov,  1986 [32] 12 y before TMJ  dysfunction Breast Adenocarcinoma NR NR
Sokolov,  1986 [32] 6 y before TMJ  dysfunction Breast Adenocarcinoma NR NR
Lowicke,  1987 [33] Yes Not reported Kidney NR NR NR
Gormann, 1987 [34] No TMJ  dysfunction Prostate Adenocarcinoma NR NR
Webster,  1988 [35] 2 y before Not reported Lung Bronchogenic carcinoma NR NR
Webster,  1988 [35] Yes TMJ  dysfunction Breast Adenocarcinoma NR NR
Cuttino,  1988 [36] 2 y before TMJ dysfunction Breast Adenocarcinoma NR NR
Rubin,  1989 [37] No TMJ  dysfunction Unknown Adenocarcinoma NR NR
Catrambone, 1990 [38] Yes Swelling Prostate Adenocarcinoma NR NR
Karr,  1991 [39] 21 m before TMJ  dysfunction Left foot Synovial sarcoma NR NR
Lalaikos,  1992 [40] Yes Swelling Liver Hepatocellular carcinoma NR NR
Van  Rensburg, 1992 [41] 2 y before TMJ  dysfunction Unknown Adenocarcinoma NR NR
MacAfee,  1993 [42] NR Swelling, paresthesia of the lip Colon Adenocarcinoma NR NR
Stavropoulos, 1993 [43] 7 y before TMJ  dysfunction Breast Adenocarcinoma NR NR
Johal,  1994 [9] No TMJ  dysfunction Kidney Clear cell carcinoma CT Died 18 m later
Nortjé,  1996 [44] 2 y before TMJ  dysfunction Nose Melanoma CT Died 6 m later
Porter  [45] Yes Swelling and pain Testicle Teratoma RT Died 5 m later
Beck-Managetta, 1997 [46] 1 y before Swelling Lung Adenocarcinoma RT Alive after 18 m
Cohen,  1998 [47] No TMJ  dysfunction Unknown Squamous cell carcinoma NR NR
Kolk,  2003 [48] Yes TMJ  dysfunction Stomach Adenocarcinoma Tumor resection + RT/CT NR
Deeming,  2003 [49] 3 y before TMJ  dysfunction Breast Cystosarcoma Phyllodes RT Died 6 m later
Smolka,  2004 [50] 2 y before Swelling, pain and malocclusion Stomach Adenocarcinoma Tumor resection + RT Alive after 8 m
Mason,  2005 [1] No Hard mass Rectosigmoid colon Adenocarcinoma None Died shortly after
Kaufmann, 2005 [51] Yes TMJ  dysfunction Lung Bronchogenic carcinoma RT NR
Duker,  2006 [52] Yes TMJ  dysfunction Breast NR NR NR
Miles,  2006 [53] 19 y before TMJ  dysfunction Breast Adenocarcinoma Tumor resection NR
Menezes,  2008 [54] No Swelling and pain Breast Adenocarcinoma NR NR
Kamatani,  2008 [55] 3 y before Swelling and pain Liver Hepatocellular carcinoma RT/CT Alive 1 y later
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Table 1 (Continued)
Authors Previous malignancy Presenting symptoms Primary site Tumor type Treatment Prognosis
Boniello, 2008 [56] No TMJ  dysfunction Lung Adenocarcinoma Tumor resection Died 6 m later
Schulze,  2008 [57] No TMJ  dysfunction Lung Bronchogenic carcinoma Biphosphonates NR
Gomes,  2009 [58] No Hard mass Unknown Adenocarcinoma NR Died 4 m later
Kruse,  2010 [59] No Hard mass and pain Lung Bronchogenic carcinoma CT Died 4 w later
Kruse,  2010 [59] 9 y before Pathologic fracture Tyroid NR NR NR
Kruse,  2010 [59] No Swelling, pain and trismus Lung Adenocarcinoma None Died 2 w later
Katsnelson, 2010 [60] No Swelling, pain and trismus Lung Bronchogenic carcinoma RT/CT NR
Cristofaro, 2011 [61] No Swelling and pain Prostate Adenocarcinoma Tumor resection + RT/CT Alive after 2 y
Cristofaro, 2011 [61] NR Swelling and trismus Kidney Clear cell carcinoma Tumor resection + CT Alive after 8 m
Patricia,  2011 [62] Yes TMJ  dysfunction Breast Adenocarcinoma RT Died 6 m later
Kelles,  2021 [63] 3 y before Swelling and trisums Kidney Clear cell carcinoma RT/CT NR
Scolozzi,  2012 [64] No TMJ  dysfunction Lung Large cell carcinoma RT/Ct Died 6 m later
Freudlsperger, 2102 [65] 5 y before TMJ  dysfunction Prostate Adenocarcinoma RT/CT NR
Puranik,  2013 [10] Yes Asymptomatic Uterine cervix Squamous cell carcinoma RT/CT NR
Qiu,  2013 [8] No Swelling Prostate Adenocarcinoma Tumor resection + CT Died 1 y later
Qiu,  2013 [8] 6 m before Swelling and numbness Penis Squamous cell carcinoma Chemotherapy Died 3 m later
Qiu,  2013 [8] No Swelling and pain Bladder Adenocarcinoma Tumor resection + CT Died 6 m later
Qiu,  2013 [8] 6 y before Swelling and pain Colon Adenocarcinoma Chemotherapy Died 3 m later
Qiu,  2013 [8] No TMJ  dysfunction Lung Bronchogenic carcinoma Chemotherapy Died 6 m later
Qiu,  2013 [8] 4 y before TMJ  dysfunction Breast Adenocarcinoma Tumor resection + CT Alive after 1 y
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Best to our knowledge, this is the ﬁrst report of NEC metastatic
pread to TMJ. The frequency of metastatic spread of any
alignancy to the mandibular condyle is low for unknown rea-
ons. It may  possibly reﬂect the poor local blood supply, the lack of
emopoietic marrow, the presence of bone cortex that limits the
pread of synovial malignancy into the marrow of the condyle or
he fact that hematogenous metastases to such a minor joint usually
epresents the ﬁnal stage of malignant disease, where generalized
etastases already should be clinically present [8–10].
Since 1941 only 73 cases of TMJ  metastases have been reported.
able 1 shows the framework summary of the results of our exten-
ive review.
Patient’s ages ranged from 15 to 85 (mean 57,7 years), 32
atients were male and 38 female, in 3 cases genre was not
eported. Adenocarcinoma is the most common histotype founded
n TMJ  metastases (56,1%), followed by squamous cellular car-
inoma (20,5%), melanoma (4,1%), clear cell carcinoma (4,1%),
epatocellular carcinoma (2,7%), synovial cell sarcoma (1,3%), large
ell carcinoma (1,3%), transitional cell carcinoma (1,3%), teratoma
1,3%) and cystosarcoma phyllodes (1,3%). Regarding the metas-
ases origins the most common primary tumor sites were breast
27,6%), lung (21%), prostate (10,5%), large bowel and rectum (6,5%),
idney (5,2%), uterus (3,9%), liver (2,6%), foot (2,6%), bladder (1,3%),
ancreas (1,3%), tyroid (1,3%), testicle (1,3%) and penis (1,3%). In
,2% of the cases primary tumor remained unknown. It’s impor-
ant to emphasize that TMJ  metastasis, sign of advanced metastatic
isease, was the ﬁrst tumoral manifestation in 28 patients (36,8%).
The lack of any other oncologic sign or symptom made the
iagnosis very difﬁcult in these cases. When history of malig-
ancy was present, TMJ  metastasis appeared with a variable latency
etween 1 month to 21 years after the ﬁrst cancer diagnosis. Even
linical presentation is highly variable and often nonspeciﬁc. Preau-
icolar swelling, masses or pathological fractures are present in
2.4% of the patients only. In 50,6% of the cases clinical presen-
ation is nonspeciﬁc and, as in our case, broadly comparable to
 mandibular dysfunction: limitation or alteration of mandibular
ovements, pain, clicks and crepitations without any sign of tumor.
his nuanced clinical presentation can thereby signiﬁcantly delay
he correct diagnosis. The symptoms can be mistaken as caused by
andibular disorders, osteomyelitis or dental problems. The non
peciﬁcity of the clinical presentation is reﬂected in a radiological
icture highly variable: are represented aggressive TMJ  destruc-
ive masses and less deﬁned osteolytic or osteoblastic alterations.
or this reason conventional radiographs are not particularly sensi-
ive in identifying metastatic lesions [45]. Radioisotopic scannings
Scintigraphy, SPECT, PET/CT) can show an abnormal uptake of
one-seeking isotopes before that a lesion can be identiﬁed on plain
adiographs, but are not speciﬁc and may  not detect metastatic
umors with minimal or absent osteoblastic activity. PET/CT detects
he abnormal glycometabolism of malignant tumor cells that is
uite different from normal cells and benign tumor cells. How-
ver it has some limitation in distinguishing inﬂammation from
alignancy [8].
Open biopsy or ﬁne-needle biopsy are therefore necessary for
he correct diagnosis.
The prognosis of mandibular metastases is very poor. Patient
urvival ranged from 2 weeks to 18 months, with a medium life
xpectancy of approximately 3 months. For patients with condy-
ar metastases, the low survival rate may  be explained because
here are often multiple concurrent metastases in the late stage of
isease [8]. For patients with multiple metastases, the most com-
on  treatment approach was combined palliative radiotherapyPlease cite this article in press as: Vaira LA, et al. The mandibular cond
Case report and review of literature. J Oral Maxillofac Surg Med  Patho
nd chemotherapy. [
[ PRESS
ry, Medicine, and Pathology xxx (2017) xxx–xxx
Surgical TMJ  metastatic resection and adjuvant radiotherapy
seem to be indicated only when it is a solitary metastases and the
primary disease is controlled [8,50,53,61].
4. Conclusions
In all the TMJ  diseases, primary or metastatic condylar tumors
should be included in the differential diagnosis, especially when
the symptoms do not respond to treatment and in patient with an
history of malignancy.
In these cases, contrasted CT scan or MRI  should be always part
of the diagnostic procedure.
However, these lesions are often a sign of advanced neoplastic
disease with very poor prognosis leaving place for surgery only in
a few selected cases.
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